![Dong Song Wei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dong Song Wei
Secrétaire Général chez SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
Fortune : 29 397 $ au 30/06/2024
Postes actifs de Dong Song Wei
Sociétés | Poste | Début | Fin |
---|---|---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Secrétaire Général | 09/01/2012 | - |
Corporate Officer/Principal | 18/08/2011 | 09/01/2012 | |
Sinopharm YiXin Pharmaceutical Co., Ltd.
![]() Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Dong Song Wei
Statistiques
Internationale
Chine | 3 |
Opérationnelle
Corporate Officer/Principal | 1 |
Corporate Secretary | 1 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Sinopharm YiXin Pharmaceutical Co., Ltd.
![]() Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Health Technology |
- Bourse
- Insiders
- Dong Song Wei
- Expérience